Health Catalyst's stock has fallen significantly following its mixed fourth-quarter earnings report, with the CEO not ruling out a potential sale as part of a review.

Health Catalyst has released highlights from its fourth-quarter earnings call, where the new CEO initiated an operational overhaul and strategic review, leading the company to refrain from providing 2026 guidance.

Health Catalyst has announced the promotion of its Chief Operating Officer to Chief Executive Officer, alongside a decision to downsize its board of directors.